Diagnosing Prostate Cancer

This information is useful for adults and older adults
Why Yale Medicine?
  • Our physicians conduct imaging scans and PSA tests to diagnose prostate cancer.
  • Our pathologists have deep expertise in reading prostate cancer biopsies.
  • Our ongoing research and clinical trials aim to find better personalized treatment plans for patients.

Following skin cancer, prostate cancer is the most common cancer among men. One in seven men in the United States will be given this diagnosis during their lifetimes, according to the American Cancer Society. 

Much progress has been made recently in efforts to combat prostate cancer, and an early diagnosis can help treatment. Prostate cancer clinical tests are vital in determining who should undergo biopsy, but it’s the examination of tissue obtained in a biopsy that will ultimately establish a cancer diagnosis. The doctor who performs this analysis is a pathologist.

Doctors know that diagnosing cancer in a patient profoundly impacts their lives and the lives of their families, says Peter A. Humphrey, MD, PhD, director of Genitourinary Pathology at Yale Medicine and professor of pathology and at Yale School of Medicine. “We know this,” he says, “and this is the basis for what drives us. Helping patients is really our driving force.”

Clinical Trials

New treatments for many conditions are tested in clinical trials, which ultimately bring lifesaving new drugs and devices to the patients who need them most. By participating in a clinical trial, you may get access to the most advanced treatments for your condition, and help determine their benefits for future patients.